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After the publication of the excellent review paper 
on vaccines to prevent otitis media, by Felix et al. (2008) 
1, we found new data on the relationship between acute 
respiratory tract infections (ARTI) caused by virus and 
otitis media in children, which we believe to be relevant 
for the readers of this well regarded journal 2-6.
Chonmaitree et al.2 isolated viruses from children 
with ARTI, and more than half of the 864 episodes of viral 
ARTI (61%) were complicated by acute otitis media: 37% 
(AOM) and 24% with otitis media with effusion (OME). 
Yano et al.3 studied 1,092 children with ARTI followed 
by AOM, and they isolated viruses from the respiratory 
secretion and the middle ear fluid and noticed that the 
highest rates of viral isolates were obtained when the 
tympanic membrane punction (tympanocentesis) was 
carried out at the early onset of symptoms in infants with 
fever. Therefore, in infections which the material collection 
happened later on, it was not possible to isolate the agent 
responsible for the alterations that caused the secondary 
bacterial infection. 
Revai et al.5 assessed the alterations caused by 
ARTI in previously healthy children aged between 6 and 
35 months, and noticed that 1/3 of the children with age 
between 6 and 24 months had alterations in their tympa-
nometries during the first week of these infections. The 
alterations were significantly more frequent and severe 
when compared to the ones seen in children older than 
two years and, according to the authors, these alterations 
can explain the greater incidence of AOM secondary to 
viral infections at this age range. 
The prevention of viral and bacterial acute respi-
ratory tract infections through the use of influenza vac-
cines and tandem vaccines against S .pneumoniae can 
substantially reduce the incidence of AOM and OME and, 
consequently, the use of antibiotics, the selection and 
spread of bacterial strains resistant to antibiotics, as well 
as the costs and risks associated with unnecessary treat-
ment1. Recently, Jansen et al.6 did a randomized, double 
blind and controlled study in which the use of influenza 
vaccine in children, with or without the concomitant 
administration of the 7-valient tandem vaccine against 
pneumococcus (PV 7), reducing in half the incidence of 
otitis for a period longer than the seasonality of influenza 
infections (winter time). 
Both the PV 7 and the vaccine against influenza are 
recommended by the Brazilian Association of Pediatrics 
for all healthy children. PV 7 is recommended for children 
older than six months and also for family members and 
people who have contact with children younger than two 
years, including family members, care takers and health 
care professionals. 
We stress the need to give two doses of influenza 
vaccine in the prime-vaccination of children aged between 
six months and nine years, and we stress that its efficacy 
varies according to the strain of the season, age, immune 
status and the presence of associated risks.
The influenza vaccine is safe and its use is capable 
of reducing up to 50% of the cases of post-influenza AOM, 
besides preventing other more severe complications, 
such as pneumonia, hospitalization and death. Influenza 
vaccine coverage is still low in children, even in risky 
groups such as asthma patients, for whom the vaccine 
is freely available from public health care facilities. Most 
non-vaccinated people, including those in greater risks, 
were not vaccinated for lack of medical advice. Physi-
cians are not only responsible for treating diseases, but 
they must also educate the population on the best way 
to avoid them.
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